SAMROTAMAB
UNII 7Z9G3BJ4RN

Substance Identification & Data

This profile provides standardized clinical and technical data for Samrotamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7Z9G3BJ4RN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2052591-32-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7Z9G3BJ4RN
CAS Registry Number
2052591-32-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SAMROTAMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171837
National Cancer Institute reference terminology for clinical and research data.
INN ID
10792
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Samrotamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SAMROTAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN LEUCINE-RICH REPEAT-CONTAINING PROTEIN 15) (HUMANIZED MOUSE MONOCLONAL PR-1498487 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL PR-1498487 .KAPPA.-CHAIN, DIMER
SAMROTAMAB [INN]

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus